• Announces expansion of cryptocurrency and blockchain education business into China
• Set to provide 24/7 coverage of the latest developments in global cryptocurrency and blockchain industry
• Launching Bitcoin Trading Academy to grow subscribers

ChineseInvestors.com, Inc. (OTCQB: CIIX) recently announced its expansion into China through the establishment of NewCoins168.com Digital Media Technology Ltd., located in Shanghai (http://ibn.fm/Ay6qa). This wholly owned foreign enterprise is registered in the China Free Trade Zone with capital of 10 million RMB ($1.58 million). This expansion strengthens the company’s vision of becoming the premier financial information website for Chinese-speaking investors. CIIX prides itself on being an innovative company providing real-time market commentary, analysis and educational services in Chinese language character sets (traditional and simplified).

The company plans to hire 10 to 15 editors in Shanghai to work in conjunction with their United States counterparts at www.NewCoins168.com, which was established in November 2017 and is headquartered in New York City’s Trump Building. This joint effort between Shanghai and the United States editors will result in 24/7 coverage of the latest in global cryptocurrency and blockchain industry developments.

CIIX, through the NewCoins168.com platform, has established itself as a well-known cryptocurrency and blockchain technology information portal for the North American Chinese community. The addition of the Shanghai enterprise positions the company to bolster its popularity among the Chinese community worldwide.

CIIX Chief Executive Officer Warren Wang announced the company’s plans to launch a Bitcoin Trading Academy in June. It is expected to broadcast on NewCoins168.com. This academy will feature a three-level bitcoin trading course for Chinese-speaking investors in the U.S. (http://ibn.fm/CtAKw). These courses will consist of trading in bitcoin futures, educational research and an explanation of ICOs. The recent announcement to spin off CIIX’s CBD-focused assets into a private company allows CIIX to remain focused on financial consulting, corporate brand building and educational services for cryptocurrency markets. CIIX’s focus has returned to its core skills as a financial service business for the Chinese-speaking community.

For more information, visit the company’s website at www.ChineseInvestors.com

• Centers for Disease Control and Prevention, in March 2018, estimated ‘economic burden’ of opioid misuse at $78.5 billion annually
• ETST plans to complete white paper, begin human clinical trials by 2019; company intends to investigate drugs that combine mineral element and cannabinoid industrial hemp oil
• Goal for biotech company is to fight opioid addiction with over-the-counter (OTC) treatment drug and a cannabinoid companion generic drug

Earth Science Tech, Inc. (OTC: ETST) is planning to fight opioid addiction in the near future by completing its white paper and beginning human clinical trials in 2019. The epidemic is projected to claim nearly 500,000 American lives by 2027, according to a study by STAT (http://ibn.fm/QW1hH).

The ETST white paper and planned human clinical studies deal with the measure of the efficacy of combination drugs against opioid dependency. The company will investigate the synergies between mineral elements and full spectrum cannabinoid industrial hemp with the goal of developing OTC and generic drugs that treat opioid addiction.

ETST is a biotech company focused on the cannabinoid, pharmaceutical and nutraceutical markets. In addition to drug research, it also performs R&D testing for medical devices. The company holds several subsidiaries, including Earth Science Pharmaceutical, Inc.; Cannabis Therapeutics, Inc.; KannaBidioiD, Inc.; and Canna Inno Laboratories, Inc., based in Montreal, Canada.

The company’s proposed OTC drug would be intended to reduce the cravings of opioid addicts. The other would be a generic designed to reduce the danger of side effects and make the first drug more effective, according to ETST. The purpose of the human trial is to develop a methodology that prevents fatal overdoses and relieves the side effects of withdrawal.

The Centers for Disease Control and Prevention (CDC), in a March 2018 revised report, estimated the ‘economic burden’ of opioid misuse at $78.5 billion annually in the U.S., including in that figure health care, addiction treatment and the involvement of the justice system. The National Institute on Drug Abuse terms it a national health crisis (http://ibn.fm/x279M).

For more information, visit the company’s website at www.EarthScienceTech.com

• Research firm Singular Research projects growth for EVIO, analyzing company’s aggressive expansion and noting performance of legal cannabis industry as tailwind
• Newly launched Canadian subsidiary EVIO Canada signs binding agreement to acquire 50 percent of Edmonton, Alberta-based Keystone Labs, Inc.
• EVIO Labs provides testing and scientific research for the regulated cannabis industry

EVIO, Inc. (OTCQB: EVIO) has launched a new wholly owned Canadian subsidiary, EVIO Canada, which concurrently signed a binding agreement to acquire 50 percent of Keystone Labs, Inc., a licensed testing facility for medical cannabis based in Edmonton, Alberta (http://ibn.fm/iauFB). Both the EVIO Labs division and Keystone Labs offer quality testing for the regulated cannabis industry.

EVIO’s aggressive expansion into new markets, and the growth of the cannabis industry, was cited by Singular Research as it projected EVIO, Inc. to reach $10 million in revenues by FY2019 (http://ibn.fm/J8Io4). It noted a New Frontier Data estimate that the U.S. legal cannabis market will grow to $24.1 billion by 2025 (http://ibn.fm/jNKYU).

EVIO, Inc. is a leading provider of cannabis testing and scientific research for the regulated cannabis industry. The company’s EVIO Labs division operates coast-to-coast, providing state-mandated ancillary services to ensure the safety and quality of the nation’s cannabis supply. EVIO is on track to have 18 of its state-of-the-art testing facilities by year-end 2018.

Keystone Labs is a contract-testing laboratory licensed to offer a wide array of testing services, including testing of medical cannabis. It holds a Health Canada Controlled Substance License and is a licensed Good Manufacturing Practices (GMP) laboratory with a Health Canada license.

The launch of the new company and its binding agreement for acquisition marks EVIO’s first international expansion. Its aggressive growth was a key factor in the positive projections of Singular Research. The report cited favorable tailwinds in the cannabis sector and initiated its coverage with a $2 price target.

Singular offered analysis of EVIO’s aggressive expansion plans, citing its exploration of “opportunities in many regions including Maryland, Pennsylvania, New York, Michigan, and Canada.” It noted that the company also has aggressive plans to tap into California’s cannabis market.

For more information, visit the company’s website at www.EVIOLabs.com

• As of July 2017, the Federal Reserve Bank estimates the value of all consumer loans in the U.S. to be more than $1.3 trillion
• Total personal loan balances finished 2017 at $117 billion, up from 2016’s $102 billion
• Nation’s strong economy is helping to build consumer confidence in personal balance sheets, signaling strong performance across multiple credit product lines, including personal consumer loans
• “Mr. Amazing Loans” brand available online in 20 states, with plans to expand to additional states

Specialized fintech company and consumer loan provider IEG Holdings Corp. (OTCQB: IEGH) issues and services direct, unsecured personal loans under the brand name “Mr. Amazing Loans” through its state-licensed operating subsidiary, Investment Evolution Corporation. Residents of 20 states (and counting) are able to apply online for consumer loans of either $5,000 or $10,000 by simply going to the company’s website and application portal at www.MrAmazingLoans.com. With a fixed APR in the range of 12 percent to 29.9 percent with a non-revolving term of five years, Mr. Amazing Loans gives consumers the option of securing a loan without ever having to meet with a lender or pay extravagant payday lender rates.

As a licensed, direct lender with licenses or certificates of authority to lend in each state, Las Vegas-based IEGH originates, processes and services personal loans to a long line of satisfied, underbanked consumers who have limited access to credit from banks and credit card companies.

The latest data from consumer credit reporting agency TransUnion puts the size of the personal loans sector at $107 billion for the second quarter of 2017. That’s a 10.8 percent increase over the same quarter in 2016 and a 132 percent increase from 2012, as detailed in an article published by SuperMoney.com (http://ibn.fm/nRyQC). A 2016 Federal Reserve survey notes that 10 percent of respondents said they applied for a personal loan that year, leaving significant room for the industry’s growth (http://ibn.fm/Wrtlc).

SeeThruEquity reports that IEGH is also looking at tapping into a $28 billion remittance market in the Philippine economy. Nearly 10 million Filipinos work abroad each year and send much of that money back home to family members, often paying exorbitant transaction fees. A progressive regulatory climate in the Philippines is seen as a favorable opening for cryptocurrencies, the report states (http://ibn.fm/NGbye).

Company CEO Paul Mathieson said that the company seeks to enter the remittance services market through the launch of a cryptocurrency by Investment Evolution Coin Ltd. (“IEC Ltd.”), a Singapore-incorporated public unlisted company managed by Mathieson (http://ibn.fm/JPOJF). Through IEC, Mathieson is collaborating with HashCash Consultants, a California-based blockchain company, to launch a new cryptocurrency – Investment Evolution Coin – that aims to make it easier and more cost-effective for the millions of Filipinos who work abroad to send money home. Mathieson also announced IEG Holdings’ shareholders will be provided with an opportunity to attain shares in Investment Evolution Coin.

“We believe potentially combining the exciting new blockchain technology with a leading sophisticated online consumer finance system, individual U.S. state lending licenses and exposure to the Philippines $28 billion OFW remittance sector is a very exciting proposition,” Mathieson said in a new release (http://ibn.fm/5fRUL).

For more information, visit the company’s websites at www.InvestmentEvolution.com and http://ibn.fm/IEGH

• Revenues increased 11 percent during 2017, reaching $60.1 million on organic growth across all categories
• Point of sale market expected to reach $106 billion by 2025
• Global retail e-commerce sales to post solid gains, rising by more than 23 percent to $2.3 trillion by end of 2017 and accounting for 10 percent of total retail sales
• Net Element processed $2.8 billion in global transactions in 2017, a 14 percent increase
• Fast Pass Funding service unveiled on proprietary Netevia platform

Net Element, Inc. (NASDAQ: NETE), a global technology and value-added solutions group focused on supporting electronic payments acceptance in a multichannel environment, continues to master the art of the transaction by delivering valuable payment solutions to merchants and consumers.

E-commerce continues to show a healthy growth pattern, as consumers are increasingly dedicated to using their mobile devices to make purchases. According to a report compiled by Accenture Consulting (http://ibn.fm/BF5bZ), consumer awareness of mobile payments is at an all-time high and first movers that deliver additional value to merchants and their customers will become the industry’s ‘game changers’.

Net Element’s new service, Fast Pass Funding, provided through the company’s proprietary Netevia platform (http://ibn.fm/LHPID), is just one of the company’s innovative value-added services offered to merchants who are tired of waiting for funding to be processed. Eligible merchants receive funds in as little as three hours during regular business days, avoiding the 12 to 24 hour wait-time they normally endure. Other value-added services offered through the Netevia platform include fast, easy merchant account opening and integration, payment conversion optimization, over 150 risk-monitoring filters and highly competitive pricing for payment acceptance services.

People around the world are expected to make 726 billion transactions using digital payment technologies by 2020, according to an article published by CNBC (http://ibn.fm/RqWqP). Based on analysis of payment trends during the years 2014 and 2015, the study – conducted by global consulting firm Capgemini – reported that debit cards accounted for the highest share of non-cash payments at 46.7 percent, while credit cards trailed behind at 19.5 percent. Non-cash transactions between 2014 and 2015 rose 11.2 percent, the highest growth of the past decade.

Net Element intends to capitalize on the mobile transaction market as it transforms to meet demands by consumers and merchants who pivot to embrace smart technology trends. The company’s key goals include continuing company growth in all key segments, driving client retention, expanding the company’s client base in particular markets, delivering value-added products to increase efficiencies and payment acceptance, continuing the development of Netevia and launching new tools to reach clients and deepen partner relations.

“We are very pleased with our 2017 progress and the strong balance sheet position as of December 31, 2017, which we believe positions the company for future growth and opportunities,” Firer said in a news release describing the company’s year in review and plans for 2018 (http://ibn.fm/3y9zf).

For more information, visit the company’s website at www.NetElement.com

• Canada on-track to legalize cannabis plant derivatives for all potential uses this year
• U.S. Senate set to debate update to 2014 Farm Bill using research showing hemp’s agricultural promise
• Global Hemp Group pioneering new commercial-scale cultivation of hemp in New Brunswick

As pending legislation authorizing the cultivation of hemp without drug enforcement oversight opens the potential for U.S. federal government friendliness toward cannabis production, Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) is busy pledging its visionary portfolio to the market for consumer goods arising from the cannabis species’ non-psychoactive varieties.

Global Hemp Group joined other players in the delicate industrial hemp arena in praising Sen. Mitch McConnell’s long-time efforts to remove low-psychoactive chemical plants from the Drug Enforcement Administration’s listing of controlled substances, as well as his recent announcement of a Hemp Farming Act Senate bill that would permanently reduce hemp to agricultural oversight (http://ibn.fm/O8EzD).

“It looks like the world of hemp in the US is about to enter a new phase and Global Hemp Group is proud to be part of this exciting new sector,” a company statement adds.

Global Hemp Group’s goal is to establish cooperation among companies interlinked in the production of hemp – an ancient domesticated crop that was once favored as a plantation crop in the United States for making paper, textiles, ropes and concrete, and that has an edible seed also millable for oils. Global Hemp Group’s joint venture with Marijuana Company of America, Inc. (OTC: MCOA) led to a plan to extract non-psychotropic cannabidiol (CBD) from industrial hemp cultivation for research purposes on the Acadian peninsula of New Brunswick, Canada, last year – the first time the plant had been grown in the region in 20 years. The research comprised the first phase of the companies’ plans to reintroduce large-scale commercial hemp cultivation in New Brunswick and establish a processing facility in the region, once it was determined that hemp could be productive there (http://ibn.fm/7EzjB).

The companies anticipate cultivating a minimum of 125 acres this year and increasing the amount of land to 1,000 acres within three years, building on the Canadian government’s drive to legalize cannabis crops for all potential applications later this year. Global Hemp Group is also preparing to build permanent processing facilities by the fall, beginning with an initial crop focused on CBD extraction but working toward the purchase of extraction equipment to obtain other types of cannabinoids and straw processed for use in building materials.

“We are excited to complete the first phase of industrial hemp trials in Canada, and we look forward to continue expanding operations in Canada,” Marijuana Company of America CEO Donald Steinberg stated last month amid the news of the New Brunswick project’s advance. “Our joint venture with (Global Hemp Group) allows (Marijuana Company of America) the opportunity to expand the Company’s operations on an international level. Both Companies are excited about the endless possibilities for hemp derived CBD product this year in Canada.”

In the United States, Sen. McConnell took the first step toward re-legalizing hemp in 2014 by using his leadership position in the Senate to support hemp pilot programs in the Farm Bill. Since then, the research has shown hemp’s potential as an agricultural commodity, according to the senator’s office (http://ibn.fm/E4xw3), and his 2018 update to the Farm Bill would build on that research. While the pending bill is being promoted in concert with Kentucky’s efforts to revitalize its historical agriculture industry, hemp de-listing also has significant potential for the West, especially in Colorado, where more hemp is grown than anywhere else in the country and a pioneering farmer introduced the efficacy of growing a commercial-scale industrial hemp crop, according to a report by High Plains Public Radio (http://ibn.fm/UEBil).

Existing law prohibits U.S. farmers from growing hemp with more than 0.3 percent THC — the most psychoactive chemical in the cannabis byproducts that produce the marijuana drug. If tests show that a hemp crop has more than the allowable level of THC, the farmer is required by law to destroy it and bear the costs. A representative of the Colorado Department of Agriculture told High Plains Public Radio that controlling THC levels is only a challenge currently because the revitalized U.S. hemp industry is still in its infancy, and that new hemp varieties have already been developed that cannot produce more than the legal amount of THC.

Hemp has a wide variety of potential applications. The Hemp Industries Association estimated annual retail value for hemp products in the United States at $573 million in 2015 (http://ibn.fm/gma2b). Of the total market, the largest percentage of products involved personal care items, with estimated sales of $146.8 million, followed by industrial applications at $116.2 million.

For more information, visit the company’s website at www.GlobalHempGroup.com

• Retail e-commerce sales expected to reach $4.88 trillion by 2021
• Net Element enables expanding scope of face-to-face and e-commerce transactions
• Company building additional transaction capabilities through blockchain project

In a world with rapidly expanding opportunities for commerce at a truly worldwide scale, one of the greatest challenges businesses face is staying abreast of the technologies that keep people linked together across the globe. Net Element, Inc. (NASDAQ: NETE) is in the business of making business happen, ensuring that sales transactions can take place across a wide array of potential platforms, globally or in-person right at a merchant’s store.

Not so far from the historical era of bartering for goods and services and yet light years ahead in terms of mobility, modern businesses and consumers are increasingly accustomed to moving merchandise without a ‘show-me-the-money’ mentality. Payment cards, emailed and texted statements and short-range electronic broadcasting all serve to verify in a confident and practically instantaneous manner that a resource of funds sufficient to cover a debt exists somewhere in the world and can be made available to another specified location somewhere in the world.

Through its brands, Net Element specializes in linking consumer mobile phones, banks, unbanked online distribution outlets and offline brick-and-mortar storefronts, providing value-added services and business analytics.  The goal is to help companies assess their competition, evaluate their own productivity and get to know their clients’ preferences in the U.S. and emerging markets around the globe.

The company’s North America Transactions Solutions business segment recorded year-over-year revenue growth of 21 percent in 2017 with a history of 28 percent growth, driven mostly by its successes with its Unified Payments subsidiary (http://ibn.fm/ImbB8). Unified Payments’ Fast Pass Funding service gives eligible merchants access to revenues in as little as three hours during regular business days, improving turnaround time for transaction processing to same-day significance.

Entry into the Enterprise Ethereum Alliance has bolstered the company’s development of secure blockchain protocols to enhance its transaction solutions, including its new Netevia multi-channel payments platform that offers end-to-end processing through easy-to-use APIs. The company’s other subsidiaries — international small content mobile solution entity Digital Provider, cloud-based point-of-sale wireless tech platform Aptito, and processor agnostic e-commerce manager PayOnline — enhance its gravitas in the industry.

Independent equity research firm JGR Capital announced in April that it had launched its small cap data coverage of Net Element as a service to investors and shareholders (http://ibn.fm/KqhVh), providing additional attention to the company’s capabilities. In January, Net Element wrapped up a $7.55 million restricted common stock and warrant private placement with an institutional investor than brought in additional funding for its blockchain initiatives.

“The Company’s balance sheet is now the strongest in its history, allowing Net Element to support future growth opportunities,” Net Element CEO Oleg Firer stated in a news release.

Cumulative data from market analyst Statista projects that retail e-commerce sales worldwide will continue to grow at a marked pace, doubling revenues to $4.88 trillion by 2021. The analysis reports that online shopping is one of the most popular online activities worldwide, but the usage varies by region. In 2016, an estimated 19 percent of all retail sales in China occurred via internet, but, in Japan, the share was only 6.7 percent. Desktop PCs are still the most popular device for placing online shopping orders, but mobile devices, especially smartphones, are catching up, the report states (http://ibn.fm/qkYh8).

For more information, visit the company’s website at www.NetElement.com

• VRCP targets gaming sector for NetoBit Cash this year as study shows that cryptocurrencies are on track to dominate online video gaming
• NetoBit Cash can be used to quickly and securely buy, sell or convert cryptocurrencies for gaming suppliers and other businesses via ATMs, tablets, PCs and mobile devices
• Study: Global cryptocurrency market to reach $6.7 billion by 2025, growing at a CAGR of more than 31 percent from 2017-2025

Virtual Crypto Technologies Inc. (OTCQB: VRCP), through wholly-owned Israeli subsidiary Virtual Crypto Technologies Ltd., has launched NetoBit Cash, a tablet device (http://ibn.fm/6w8SV) enabling video game suppliers and other businesses to securely buy, sell or convert bitcoin and other cryptocurrencies in real time.

VRCP is targeting the online video game market, as cryptocurrencies are positioned to dominate that industry, according to a March 2018 study (http://ibn.fm/F2gFw) by Worldwide Asset eXchange (WAX™). Findings from the survey of 1,000 gamers in the U.S. suggest that there is a pent up demand for cryptocurrency services, with 80 percent interested in using cryptocurrencies for video game transactions.

NetoBit Cash enables gaming suppliers to meet that challenge, permitting users to buy or sell cryptocurrencies quickly, shortening the confirmation and validation timeframe to just seconds, as compared to today’s 20-minute to 24-hour range. This faster execution lowers the risk of fraud while reducing the complexity of the online purchase experience.

The product also searches several crypto exchanges simultaneously for the lowest exchange rate and commission offered, rather than just the customary one. VRCP’s algorithms can locate the ‘best deal’ combination of coin rate and commission at the time of purchase (the most attractive balance of coin rate and commission). This feature, plus confirmation speed, enables the company to offer a guarantee against currency volatility during the trade/exchange approval process of up to $3,000 per trade.

In addition, connecting with multiple exchanges at a given moment means that the VRCP system can divide a single payment across exchanges, allowing purchase of more than a single exchange can provide, thereby addressing common liquidity problems.

Finally, VRCP offers backroom capabilities to manage risk, operate a large number of cryptocurrency points-of-sale, conform to regulations and provide transaction statistical data.

A study by Transparency Market Research projects that the global cryptocurrency market and its related hardware and software will reach $6.7 billion by 2025, growing at a CAGR of greater than 31 percent from 2017-2025 (http://ibn.fm/n6LRO).

For more information, visit the company’s website at www.Virtual-Crypto.com

• Global Point Of Care (POC) diagnostics market projected to grow from $23.71 billion in 2017 to $38.13 billion in 2022
• Patented diagnostic technology for POC devices
• Initial development of MIDS Cardiac™, a POC device for early and rapid cardiac biomarker detection
• Global cardiac biomarkers market expected to reach $13.3 billion by 2024
• Delivering MIDS Cardiac™ would allow the technology to be applied to multiple other immunoassay tests with a global market that’s projected to be worth $25.45 billion by 2021

The global point-of-care (POC) diagnostics market is forecast to grow at a CAGR of 10 percent, from $23.71 billion in 2017 to $38.13 billion in 2022, according to a recent Research and Markets report (http://ibn.fm/z3pLX). Zenosense, Inc. (OTC: ZENO) is well positioned to capitalize on the projected growth in this market through the development and commercialization of its MIDS Cardiac device, a game changing POC technology.

Through its joint venture ownership of MIDS Medical Limited (MML), development is being carried out at MML’s laboratories at the Sci-Tech Daresbury campus in the UK, a facility that’s internationally recognized for leading-edge scientific research and commercial development. MML has exclusive rights to the MIDS technology platform, protected by patents granted in the U.S. and China and patent applications in other countries around the world.

MIDS Cardiac is being developed as a cost-effective handheld device reading a disposable blood test strip to conduct high sensitivity cardiac diagnostic assays. The analytical sensitivity gap between central laboratory testing platforms and existing POC testing devices is significant. It has hindered the adoption of POC tests, even though they have a far quicker turnaround time. POC devices, like analyzers, generally rely on optical detection of commonly used paramagnetic assay beads. This bulky technology has not been successfully miniaturized into high sensitivity capable, hand-held devices.

MIDS’ key differentiator is its unique ability to detect and measure these assay beads by their total aggregated nano-magnetic signal, rather than conventional optical detection. Initial testing has demonstrated that this novel approach should enable MML to develop a highly sensitive, accurate, miniaturized device to support high-sensitivity cardiac biomarker testing. Such a POC device could be used in the emergency room, a doctor’s office, the bedside and by paramedics in emergency situations, such as in an ambulance.

A POC device for easy, accurate and rapid testing of very low levels of cardiac biomarkers is a critical unmet medical need. Currently, troponin is the preferred biomarker for AMI. However, high sensitivity analysis can currently only be conducted by skilled operators using expensive equipment in central laboratories. This procedure typically requires at least a 60 minutes turnaround time, which is often way too long when time is critical. MIDS Cardiac is being developed to be the first POC device to be able to conduct truly high-sensitivity diagnostic assays, notably to identify and measure extremely low levels of cardiac biomarkers, particularly troponin, at the POC. This would significantly speed up triage, diagnosis and treatment of patients reporting chest pain symptoms that may be indicative of heart attack, allowing a far quicker rule-in or rule-out for AMI. The cost-effective MIDS Cardiac device is being designed for use at POC by minimally trained emergency professionals, with the ability to provide troponin results within three minutes and more extensive biomarker testing within eight minutes, from a pinprick of blood.

MML’s initial testing of the company’s ‘Hybrid Strip’ system was carried out in late 2017. The Hybrid Strip, for initial testing purposes, aims to replicate as far as possible the planned MIDS ‘Lab on Chip’ technology, which is expected to give a very high level of accuracy, equal to or better than laboratory analyzers.

MML’s initial test results show that a range of sizes of commercially available assay beads could be nano-magnetically detected in very low quantities. In a news release, managing director and chief scientific officer of MML Dr. Nasser Djennati said, “These results come in at the very high end of detection expectations, even at this Hybrid Strip stage. As we move forward into true Lab on Chip construction, I expect detection levels to improve further still.”

Every 43 seconds, someone in the U.S. has a heart attack, and every 60 seconds someone dies from a heart disease-related event. Zenosense has expressed confidence that MIDS Cardiac will provide a cost-effective, fast, accurate and reliable device for emergency diagnosis of AMI by medical professionals in low-resource settings.

The MIDS platform technology is also expected to have a far wider application beyond cardiac testing, for the cost-effective POC testing of numerous medical conditions. MML’s ultimate aim is to develop a multi-capability, hand-held device with laboratory analyzer ‘Gold Standard’ accuracy, for the diagnosis of conditions such as cancer, stroke, inflammatory/autoimmune disease, bacterial and viral infections and many more indications.

For more information, visit the company’s website at www.Zenosense.com

• Online bank accounts offered for state licensed medical marijuana establishments
• Green offers banking and financial processing system solutions to the cannabis industry
• The online signup of merchant clients has far exceeded expectations

Medical Cannabis Payment Solutions (OTC: REFG) is set to offer bank accounts for state licensed medical marijuana establishments. By providing online banking, REFG enables cannabis providers to address the problem of limited to no bank support due to federal regulations. “Because of our end-to end payment system, our successful government relations program, our focus on regulatory compliance, we believe we offer the nation’s only truly compliant payment and banking solution for state sanctioned marijuana,” Jeremy Roberts, CEO of REFG, stated in a news release. “We believe we are uniquely positioned to comply with all federal guidance and applicable laws and regulations” (http://ibn.fm/KSAfC). This state-of-the-art financial service is the security and management answer that the previously cash-only cannabis industry has been needing.

REFG has brought to market the Green platform, the first and only comprehensive card processing operation of its kind to serve the state-sanctioned cannabis industry. Green is a top-tier, level-one gateway payment processing system that tracks sales and taxes, eliminates cash-only transactions and empowers businesses with an advanced client management system. Green’s virtual banking system provides premier security and accessibility to funds for the merchant. It is a full banking and financial processing system for an industry that has lacked these much-needed services.

The company’s platform, previously only available to medical cannabis merchants, is now available to the entire cannabis industry. Licensed establishments interested in using the Green platform can now signup online. The enrollment process only takes a few minutes, given a business address and proof of licensure in the client’s respective state. The Green platform allows dispensaries to take electronic payments and deposit cash securely while remaining in complete FinCEN compliance. The response of the cannabis industry to online enrollment has far exceeded expectations. The increased web traffic alone reveals the market demand for this secure and efficient banking solution.

For more information, visit the company’s website at www.Take.green